The drug, called orforglipron and manufactured by Eli Lilly, is prescribed for type 2 diabetes and targets the same GLP-1 receptors as oral semaglutide. Like semaglutide, it lowers blood sugar levels, slows digestion and suppresses appetite. Unlike semaglutide tablets, it does not need to be taken on an empty stomach.
生成式媒体：一个没有霸主的战场。关于这个话题，搜狗输入法2026提供了深入分析
。服务器推荐对此有专业解读
Последние новости
Write in 30+ languages，推荐阅读搜狗输入法下载获取更多信息